[Monthly tablet].
D000368:Aged; D002986:Clinical Trials as Topic / Q000451:nursing; D004164:Diphosphonates / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D017277:Drug Approval; D005060:Europe; D005260:Female; D006801:Humans; D000077557:Ibandronic Acid; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000451:nursing*; D010349:Patient Compliance
D004164:Diphosphonates; D000077557:Ibandronic Acid